Nippon Care Supply Co., Ltd. (TYO:2393)
Japan · Delayed Price · Currency is JPY 2,373.00
-22.00 (-0.92%)
Jun 2, 2026, 9:24 AM JST
Nippon Care Supply Income Statement
Financials in millions JPY. Fiscal year is April - March.
Millions JPY. Fiscal year is Apr - Mar.
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
| 34,929 | 32,006 | 28,592 | 25,892 | 23,297 | |
Revenue Growth (YoY) | 9.13% | 11.94% | 10.43% | 11.14% | 10.85% |
Cost of Revenue | 22,139 | 20,717 | 18,342 | 16,418 | 14,478 |
Gross Profit | 12,790 | 11,289 | 10,250 | 9,474 | 8,819 |
Selling, General & Admin | 9,696 | 8,829 | 8,077 | 7,354 | 6,495 |
Operating Expenses | 9,696 | 8,830 | 8,077 | 7,356 | 6,492 |
Operating Income | 3,094 | 2,459 | 2,173 | 2,118 | 2,327 |
Interest Expense | -15 | -13 | -3 | - | - |
Interest & Investment Income | 1 | - | - | - | - |
Earnings From Equity Investments | 22 | 30 | 16 | 11 | 22 |
Currency Exchange Gain (Loss) | - | - | 4 | 2 | 5 |
Other Non Operating Income (Expenses) | 19 | 8 | 11 | 9 | 8 |
EBT Excluding Unusual Items | 3,121 | 2,484 | 2,201 | 2,140 | 2,362 |
Gain (Loss) on Sale of Investments | - | - | 24 | - | -2 |
Gain (Loss) on Sale of Assets | 4 | 1 | - | - | - |
Asset Writedown | -5 | -16 | -21 | -13 | -4 |
Other Unusual Items | -1 | 30 | - | - | 21 |
Pretax Income | 3,119 | 2,499 | 2,204 | 2,127 | 2,377 |
Income Tax Expense | 862 | 708 | 626 | 613 | 702 |
Earnings From Continuing Operations | 2,257 | 1,791 | 1,578 | 1,514 | 1,675 |
Minority Interest in Earnings | 1 | 1 | - | - | - |
Net Income | 2,258 | 1,792 | 1,578 | 1,514 | 1,675 |
Net Income to Common | 2,258 | 1,792 | 1,578 | 1,514 | 1,675 |
Net Income Growth | 26.00% | 13.56% | 4.23% | -9.61% | -3.29% |
Shares Outstanding (Basic) | 16 | 16 | 16 | 16 | 16 |
Shares Outstanding (Diluted) | 16 | 16 | 16 | 16 | 16 |
Shares Change (YoY) | 0.01% | -0.00% | - | - | - |
EPS (Basic) | 145.31 | 115.33 | 101.56 | 97.44 | 107.80 |
EPS (Diluted) | 145.31 | 115.33 | 101.56 | 97.44 | 107.80 |
EPS Growth | 26.00% | 13.56% | 4.23% | -9.61% | -3.29% |
Free Cash Flow | 2,732 | 539 | -307 | -795 | -635 |
Free Cash Flow Per Share | 175.82 | 34.69 | -19.76 | -51.16 | -40.87 |
Dividend Per Share | - | 70.000 | 70.000 | 70.000 | 60.000 |
Dividend Growth | - | - | - | 16.67% | 30.44% |
Gross Margin | 36.62% | 35.27% | 35.85% | 36.59% | 37.85% |
Operating Margin | 8.86% | 7.68% | 7.60% | 8.18% | 9.99% |
Profit Margin | 6.46% | 5.60% | 5.52% | 5.85% | 7.19% |
Free Cash Flow Margin | 7.82% | 1.68% | -1.07% | -3.07% | -2.73% |
EBITDA | 10,387 | 9,429 | 8,347 | 7,816 | 7,679 |
EBITDA Margin | 29.74% | 29.46% | 29.19% | 30.19% | 32.96% |
D&A For EBITDA | 7,293 | 6,970 | 6,174 | 5,698 | 5,352 |
EBIT | 3,094 | 2,459 | 2,173 | 2,118 | 2,327 |
EBIT Margin | 8.86% | 7.68% | 7.60% | 8.18% | 9.99% |
Effective Tax Rate | 27.64% | 28.33% | 28.40% | 28.82% | 29.53% |